REXULTI BREXPIPRAZOLE Trademark

Trademark Overview


On Monday, June 15, 2015, a trademark application was filed for REXULTI BREXPIPRAZOLE with the United States Patent and Trademark Office. The USPTO has given the REXULTI BREXPIPRAZOLE trademark a serial number of 86662242. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, September 21, 2022. This trademark is owned by H. Lundbeck A/S. The REXULTI BREXPIPRAZOLE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression and schizophrenia; all of the foregoing containing brexpiprazole
rexulti brexpiprazole

General Information


Serial Number86662242
Word MarkREXULTI BREXPIPRAZOLE
Filing DateMonday, June 15, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, September 21, 2022
Registration Number5052422
Registration DateTuesday, October 4, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 19, 2016

Trademark Statements


Description of MarkThe mark consists of two triangular linking shapes in gold and green with "REXULTI" in green between the edge of the green link and the word "BREXPIPRAZOLE" in black underneath "REXULTI".
Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression and schizophrenia; all of the foregoing containing brexpiprazole
Indication of Colors claimedThe color(s) gold, green and black is/are claimed as a feature of the mark.
NOT AVAILABLE"BREXPIPRAZOLE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 18, 2015
Primary Code005
First Use Anywhere DateFriday, July 10, 2015
First Use In Commerce DateFriday, July 10, 2015

Trademark Owner History


Party NameOTSUKA PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCHIYODA-KU, TOKYO 101-8535
JP

Party NameOTSUKA PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTOKYO
JP

Party NameOTSUKA PHARMACEUTICAL CO., LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressTOKYO
JP

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events


Event DateEvent Description
Thursday, June 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 18, 2015NEW APPLICATION ENTERED
Friday, June 19, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 15, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 29, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 11, 2015ASSIGNED TO EXAMINER
Wednesday, August 12, 2015NON-FINAL ACTION WRITTEN
Friday, October 2, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 12, 2015NON-FINAL ACTION E-MAILED
Friday, October 2, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 21, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 8, 2015ASSIGNED TO LIE
Tuesday, December 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 9, 2015SUSPENSION LETTER WRITTEN
Wednesday, December 9, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 9, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, March 2, 2016TEAS AMENDMENT OF USE RECEIVED
Wednesday, March 2, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, March 2, 2016USE AMENDMENT FILED
Thursday, March 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 4, 2016AMENDMENT TO USE PROCESSING COMPLETE
Friday, March 4, 2016DATA MODIFICATION COMPLETED
Wednesday, June 29, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 4, 2016USE AMENDMENT ACCEPTED
Saturday, March 5, 2016NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, June 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2016REGISTERED-PRINCIPAL REGISTER
Monday, October 4, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, October 4, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 21, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 25, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 21, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 21, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.